nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR2—type 2 diabetes mellitus	0.185	0.914	CbGaD
Tasosartan—Irbesartan—type 2 diabetes mellitus	0.138	0.389	CrCtD
Tasosartan—Valsartan—type 2 diabetes mellitus	0.118	0.33	CrCtD
Tasosartan—Losartan—type 2 diabetes mellitus	0.1	0.281	CrCtD
Tasosartan—AGTR1—Valsartan—type 2 diabetes mellitus	0.0571	0.329	CbGbCtD
Tasosartan—AGTR1—Irbesartan—type 2 diabetes mellitus	0.0509	0.293	CbGbCtD
Tasosartan—AGTR1—Losartan—type 2 diabetes mellitus	0.0328	0.189	CbGbCtD
Tasosartan—Forasartan—Irbesartan—type 2 diabetes mellitus	0.0198	0.0847	CrCrCtD
Tasosartan—Valsartan—Irbesartan—type 2 diabetes mellitus	0.0198	0.0847	CrCrCtD
Tasosartan—CYP3A4—type 2 diabetes mellitus	0.0174	0.086	CbGaD
Tasosartan—Irbesartan—Valsartan—type 2 diabetes mellitus	0.0168	0.0721	CrCrCtD
Tasosartan—Forasartan—Valsartan—type 2 diabetes mellitus	0.0168	0.0721	CrCrCtD
Tasosartan—Azilsartan medoxomil—Losartan—type 2 diabetes mellitus	0.0165	0.0709	CrCrCtD
Tasosartan—Olmesartan—Irbesartan—type 2 diabetes mellitus	0.0157	0.0673	CrCrCtD
Tasosartan—Valsartan—Losartan—type 2 diabetes mellitus	0.0143	0.0613	CrCrCtD
Tasosartan—Forasartan—Losartan—type 2 diabetes mellitus	0.0143	0.0613	CrCrCtD
Tasosartan—Losartan—Irbesartan—type 2 diabetes mellitus	0.0143	0.0613	CrCrCtD
Tasosartan—Irbesartan—Losartan—type 2 diabetes mellitus	0.0143	0.0613	CrCrCtD
Tasosartan—Olmesartan—Valsartan—type 2 diabetes mellitus	0.0134	0.0572	CrCrCtD
Tasosartan—Candesartan—Irbesartan—type 2 diabetes mellitus	0.0131	0.0563	CrCrCtD
Tasosartan—Losartan—Valsartan—type 2 diabetes mellitus	0.0122	0.0521	CrCrCtD
Tasosartan—Olmesartan—Losartan—type 2 diabetes mellitus	0.0114	0.0487	CrCrCtD
Tasosartan—Candesartan—Valsartan—type 2 diabetes mellitus	0.0112	0.0479	CrCrCtD
Tasosartan—Candesartan—Losartan—type 2 diabetes mellitus	0.0095	0.0407	CrCrCtD
Tasosartan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.005	0.0288	CbGbCtD
Tasosartan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00446	0.0257	CbGbCtD
Tasosartan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00408	0.0235	CbGbCtD
Tasosartan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00356	0.0205	CbGbCtD
Tasosartan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00322	0.0186	CbGbCtD
Tasosartan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00244	0.0141	CbGbCtD
Tasosartan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00234	0.0135	CbGbCtD
Tasosartan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00234	0.0135	CbGbCtD
Tasosartan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00222	0.0128	CbGbCtD
Tasosartan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00165	0.0095	CbGbCtD
Tasosartan—CYP3A4—Losartan—type 2 diabetes mellitus	0.00151	0.00869	CbGbCtD
Tasosartan—AGTR2—cardiovascular system—type 2 diabetes mellitus	0.0015	0.194	CbGeAlD
Tasosartan—AGTR2—kidney—type 2 diabetes mellitus	0.00147	0.19	CbGeAlD
Tasosartan—AGTR1—artery—type 2 diabetes mellitus	0.000969	0.125	CbGeAlD
Tasosartan—AGTR2—liver—type 2 diabetes mellitus	0.00093	0.12	CbGeAlD
Tasosartan—AGTR1—endothelium—type 2 diabetes mellitus	0.000818	0.106	CbGeAlD
Tasosartan—AGTR1—nephron tubule—type 2 diabetes mellitus	0.000375	0.0483	CbGeAlD
Tasosartan—AGTR1—cardiovascular system—type 2 diabetes mellitus	0.000337	0.0434	CbGeAlD
Tasosartan—AGTR1—kidney—type 2 diabetes mellitus	0.000329	0.0425	CbGeAlD
Tasosartan—Irbesartan—EDNRA—type 2 diabetes mellitus	0.000325	0.353	CrCbGaD
Tasosartan—AGTR1—cortex of kidney—type 2 diabetes mellitus	0.000321	0.0414	CbGeAlD
Tasosartan—AGTR1—adipose tissue—type 2 diabetes mellitus	0.000297	0.0383	CbGeAlD
Tasosartan—AGTR1—liver—type 2 diabetes mellitus	0.000208	0.0268	CbGeAlD
Tasosartan—Olmesartan—ABCC2—type 2 diabetes mellitus	0.000171	0.186	CrCbGaD
Tasosartan—CYP3A4—kidney—type 2 diabetes mellitus	0.000121	0.0156	CbGeAlD
Tasosartan—Irbesartan—CYP1A2—type 2 diabetes mellitus	8.89e-05	0.0966	CrCbGaD
Tasosartan—Losartan—ACE—type 2 diabetes mellitus	8.08e-05	0.0877	CrCbGaD
Tasosartan—CYP3A4—liver—type 2 diabetes mellitus	7.65e-05	0.00986	CbGeAlD
Tasosartan—Valsartan—ALB—type 2 diabetes mellitus	6.77e-05	0.0736	CrCbGaD
Tasosartan—Irbesartan—CYP3A4—type 2 diabetes mellitus	5.89e-05	0.0639	CrCbGaD
Tasosartan—Losartan—CYP1A2—type 2 diabetes mellitus	5.73e-05	0.0622	CrCbGaD
Tasosartan—Losartan—CYP3A4—type 2 diabetes mellitus	3.79e-05	0.0412	CrCbGaD
Tasosartan—Losartan—ALB—type 2 diabetes mellitus	3.31e-05	0.0359	CrCbGaD
Tasosartan—AGTR1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	1.41e-05	0.000548	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	1.41e-05	0.000545	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.37e-05	0.000533	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	1.36e-05	0.000528	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	1.36e-05	0.000528	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.35e-05	0.000523	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	1.35e-05	0.000522	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—AGT—type 2 diabetes mellitus	1.35e-05	0.000522	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—C3—type 2 diabetes mellitus	1.32e-05	0.000511	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	1.32e-05	0.00051	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	1.31e-05	0.000507	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	1.28e-05	0.000498	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	1.28e-05	0.000495	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	1.27e-05	0.000493	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.26e-05	0.000487	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.25e-05	0.000486	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.25e-05	0.000486	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	1.25e-05	0.000483	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	1.25e-05	0.000482	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	1.24e-05	0.00048	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.23e-05	0.000478	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.23e-05	0.000476	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.23e-05	0.000476	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	1.22e-05	0.000475	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	1.22e-05	0.000474	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.21e-05	0.00047	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GIP—type 2 diabetes mellitus	1.2e-05	0.000465	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	1.19e-05	0.00046	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.16e-05	0.000449	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	1.16e-05	0.000448	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	1.14e-05	0.000441	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	1.14e-05	0.000441	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	1.13e-05	0.000439	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	1.13e-05	0.000438	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	1.13e-05	0.000436	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	1.12e-05	0.000432	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	1.11e-05	0.000431	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	1.11e-05	0.00043	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.1e-05	0.000425	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	1.09e-05	0.000422	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	1.06e-05	0.00041	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—INS—type 2 diabetes mellitus	1.05e-05	0.000407	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.03e-05	0.0004	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GCG—type 2 diabetes mellitus	1.03e-05	0.000399	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	1.02e-05	0.000395	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	1.01e-05	0.000393	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.01e-05	0.000393	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.01e-05	0.000393	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	1.01e-05	0.000393	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.01e-05	0.000391	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	9.85e-06	0.000382	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	9.83e-06	0.000381	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	9.77e-06	0.000379	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	9.7e-06	0.000376	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	9.64e-06	0.000374	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.64e-06	0.000373	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.2e-06	0.000356	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.2e-06	0.000356	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	9.17e-06	0.000355	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	9.09e-06	0.000352	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	9.01e-06	0.000349	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	9.01e-06	0.000349	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	8.88e-06	0.000344	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	8.78e-06	0.00034	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	8.78e-06	0.00034	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AVP—type 2 diabetes mellitus	8.76e-06	0.000339	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	8.76e-06	0.000339	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	8.74e-06	0.000339	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	8.71e-06	0.000338	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RELA—type 2 diabetes mellitus	8.66e-06	0.000336	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	8.63e-06	0.000335	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	8.33e-06	0.000323	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	8.2e-06	0.000318	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	8.11e-06	0.000314	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	8.02e-06	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—C3—type 2 diabetes mellitus	8.01e-06	0.00031	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	8e-06	0.00031	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	7.91e-06	0.000307	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	7.91e-06	0.000307	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.88e-06	0.000305	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	7.82e-06	0.000303	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.81e-06	0.000303	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	7.77e-06	0.000301	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.76e-06	0.000301	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—INSR—type 2 diabetes mellitus	7.73e-06	0.000299	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	7.61e-06	0.000295	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	7.59e-06	0.000294	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	7.58e-06	0.000294	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	7.55e-06	0.000292	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	7.45e-06	0.000289	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.38e-06	0.000286	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.3e-06	0.000283	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—C3—type 2 diabetes mellitus	7.28e-06	0.000282	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	7.23e-06	0.00028	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.16e-06	0.000277	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	7.03e-06	0.000273	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	7.02e-06	0.000272	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	7.02e-06	0.000272	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AGT—type 2 diabetes mellitus	6.91e-06	0.000268	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.83e-06	0.000264	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SRC—type 2 diabetes mellitus	6.81e-06	0.000264	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.8e-06	0.000263	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.8e-06	0.000263	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.68e-06	0.000259	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.65e-06	0.000258	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.65e-06	0.000258	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.63e-06	0.000257	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.57e-06	0.000255	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	6.39e-06	0.000248	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	6.19e-06	0.00024	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	6.16e-06	0.000239	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	6.15e-06	0.000238	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GCG—type 2 diabetes mellitus	6.08e-06	0.000236	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.08e-06	0.000236	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	6.08e-06	0.000236	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	6.06e-06	0.000235	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.98e-06	0.000232	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.97e-06	0.000231	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.96e-06	0.000231	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.69e-06	0.000221	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.59e-06	0.000217	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.59e-06	0.000217	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	5.29e-06	0.000205	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.24e-06	0.000203	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AVP—type 2 diabetes mellitus	5.17e-06	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.17e-06	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.15e-06	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.13e-06	0.000199	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.07e-06	0.000197	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOB—type 2 diabetes mellitus	5e-06	0.000194	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.98e-06	0.000193	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.92e-06	0.000191	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.77e-06	0.000185	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	4.69e-06	0.000182	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.67e-06	0.000181	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.58e-06	0.000178	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.48e-06	0.000174	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.4e-06	0.00017	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—C3—type 2 diabetes mellitus	4.3e-06	0.000167	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.23e-06	0.000164	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	4.1e-06	0.000159	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	4.1e-06	0.000159	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.1e-06	0.000159	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.09e-06	0.000158	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.08e-06	0.000158	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.02e-06	0.000156	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOE—type 2 diabetes mellitus	4e-06	0.000155	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LEP—type 2 diabetes mellitus	4e-06	0.000155	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.96e-06	0.000153	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	3.89e-06	0.000151	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	3.89e-06	0.000151	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.77e-06	0.000146	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	3.71e-06	0.000144	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.57e-06	0.000138	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	3.42e-06	0.000133	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	3.42e-06	0.000133	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—INS—type 2 diabetes mellitus	3.42e-06	0.000132	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.36e-06	0.00013	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.31e-06	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	3.3e-06	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	3.3e-06	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	3.3e-06	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.3e-06	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	3.3e-06	0.000128	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.3e-06	0.000128	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.29e-06	0.000127	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	3.2e-06	0.000124	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.14e-06	0.000122	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	3.02e-06	0.000117	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	3.02e-06	0.000117	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3e-06	0.000116	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3e-06	0.000116	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	2.95e-06	0.000114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.82e-06	0.000109	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	2.81e-06	0.000109	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	2.81e-06	0.000109	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	2.81e-06	0.000109	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	2.69e-06	0.000104	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	2.69e-06	0.000104	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	2.59e-06	0.0001	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	2.59e-06	0.0001	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.57e-06	9.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.55e-06	9.87e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.54e-06	9.86e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.53e-06	9.8e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.5e-06	9.7e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.5e-06	9.7e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.5e-06	9.7e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.41e-06	9.32e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.38e-06	9.22e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.35e-06	9.12e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.33e-06	9.04e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.22e-06	8.59e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.2e-06	8.54e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.16e-06	8.37e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.13e-06	8.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.13e-06	8.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.13e-06	8.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.13e-06	8.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.04e-06	7.91e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.98e-06	7.68e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.94e-06	7.53e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.9e-06	7.35e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.77e-06	6.87e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.74e-06	6.73e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.74e-06	6.73e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.7e-06	6.6e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.69e-06	6.55e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.69e-06	6.55e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.69e-06	6.55e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.68e-06	6.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.65e-06	6.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.63e-06	6.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.52e-06	5.88e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.52e-06	5.88e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.52e-06	5.88e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.49e-06	5.79e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.49e-06	5.77e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.48e-06	5.72e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.44e-06	5.6e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.39e-06	5.38e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.38e-06	5.34e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.37e-06	5.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.37e-06	5.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.32e-06	5.1e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.32e-06	5.1e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.13e-06	4.39e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.13e-06	4.39e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.13e-06	4.37e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.11e-06	4.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.08e-06	4.19e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.05e-06	4.08e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.03e-06	4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.01e-06	3.92e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.01e-06	3.9e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	9.81e-07	3.8e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	9.69e-07	3.75e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	9.29e-07	3.6e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	9.12e-07	3.53e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.83e-07	3.42e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	8.68e-07	3.36e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	8.65e-07	3.35e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	8.55e-07	3.31e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	7.54e-07	2.92e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	7.39e-07	2.86e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.78e-07	2.63e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.48e-07	2.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.48e-07	2.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.93e-07	2.3e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.98e-07	1.15e-05	CbGpPWpGaD
